Canature Health Explores Exosome Therapy Applications in Pet Anti-Aging and Wellness

Deep News03-15

Following the March 15 evening broadcast by China Central Television that exposed regulatory issues in the cosmetic use of exosomes, public attention toward this substance has surged significantly. It is understood that China's National Medical Products Administration has released a draft guideline seeking public comments on incorporating exosomes into pharmaceutical regulatory oversight. However, exosome research remains in the experimental stage within the medical community, with its mechanisms of action and clinical efficacy still not clearly established. To date, no exosome-based drugs have been approved for market sale in China.

A-share listed company Canature Health Technology Co., Ltd. previously disclosed on an investor communication platform that its wholly-owned subsidiary, Hainan Canature Cell, acquired Laisen Yuan, whose business focus includes pet health and anti-aging. The subsidiary aims to employ advanced biotechnological approaches—such as stem cell therapy, NK cell activation, exosome therapy, and NMN supplements—to delay aging in pets, enhance their immunity, and improve overall health.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1139859020?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-15 22:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139859020","market":"sh","top_or_hot":-1,"title":"Canature Health Explores Exosome Therapy Applications in Pet Anti-Aging and Wellness","media":"Deep News","content":"<p>Following the March 15 evening broadcast by China Central Television that exposed regulatory issues in the cosmetic use of exosomes, public attention toward this substance has surged significantly. It is understood that China's National Medical Products Administration has released a draft guideline seeking public comments on incorporating exosomes into pharmaceutical regulatory oversight. However, exosome research remains in the experimental stage within the medical community, with its mechanisms of action and clinical efficacy still not clearly established. To date, no exosome-based drugs have been approved for market sale in China.</p>\n<p>A-share listed company Canature Health Technology Co., Ltd. previously disclosed on an investor communication platform that its wholly-owned subsidiary, Hainan Canature Cell, acquired Laisen Yuan, whose business focus includes pet health and anti-aging. The subsidiary aims to employ advanced biotechnological approaches—such as stem cell therapy, NK cell activation, exosome therapy, and NMN supplements—to delay aging in pets, enhance their immunity, and improve overall health.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canature Health Explores Exosome Therapy Applications in Pet Anti-Aging and Wellness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanature Health Explores Exosome Therapy Applications in Pet Anti-Aging and Wellness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-03-15 22:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Following the March 15 evening broadcast by China Central Television that exposed regulatory issues in the cosmetic use of exosomes, public attention toward this substance has surged significantly. It is understood that China's National Medical Products Administration has released a draft guideline seeking public comments on incorporating exosomes into pharmaceutical regulatory oversight. However, exosome research remains in the experimental stage within the medical community, with its mechanisms of action and clinical efficacy still not clearly established. To date, no exosome-based drugs have been approved for market sale in China.</p>\n<p>A-share listed company Canature Health Technology Co., Ltd. previously disclosed on an investor communication platform that its wholly-owned subsidiary, Hainan Canature Cell, acquired Laisen Yuan, whose business focus includes pet health and anti-aging. The subsidiary aims to employ advanced biotechnological approaches—such as stem cell therapy, NK cell activation, exosome therapy, and NMN supplements—to delay aging in pets, enhance their immunity, and improve overall health.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0150","symbol_name":"环保概念","start_time":0,"source_url":"","article_id":"1139859020","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139859020","pubTimestamp":1773585115,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Following the March 15 evening broadcast by China Central Television that exposed regulatory issues in the cosmetic use of exosomes, public attention toward this substance has surged significantly....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159982":"中证500","300272":"开能健康","399300":"沪深300","BK0150":"环保概念","BK0135":"污水处理","BK0042":"基因检测","BK0020":"浦东新区","BK0224":"电气机械","BK0046":"生物疫苗"},"translate_title":"Canature Health探索外泌体疗法在宠物抗衰老和健康中的应用","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159982":1,"300272":1,"399300":1},"content_text":"Following the March 15 evening broadcast by China Central Television that exposed regulatory issues in the cosmetic use of exosomes, public attention toward this substance has surged significantly. It is understood that China's National Medical Products Administration has released a draft guideline seeking public comments on incorporating exosomes into pharmaceutical regulatory oversight. However, exosome research remains in the experimental stage within the medical community, with its mechanisms of action and clinical efficacy still not clearly established. To date, no exosome-based drugs have been approved for market sale in China.\nA-share listed company Canature Health Technology Co., Ltd. previously disclosed on an investor communication platform that its wholly-owned subsidiary, Hainan Canature Cell, acquired Laisen Yuan, whose business focus includes pet health and anti-aging. The subsidiary aims to employ advanced biotechnological approaches—such as stem cell therapy, NK cell activation, exosome therapy, and NMN supplements—to delay aging in pets, enhance their immunity, and improve overall health.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1139859020","isCrawlerRequest":true}